Literature DB >> 12773276

Management of fibromyalgia.

Ashwin A Patkar1, Louai Bilal, Prakash S Masand.   

Abstract

Fibromyalgia is characterized by widespread pain, persistent fatigue, nonrestorative sleep, and generalized morning stiffness. The diagnosis is based on patients' reports of pain and fatigue, clinical findings of multiple tender points, and exclusion of a range of connective tissue and other medical disorders. Treatment of fibromyalgia is multidisciplinary with an emphasis on active patient participation, medications, cognitive behavioral therapy, and physical modalities. No single medication has been found to effectively control all the symptoms, and a rational combination of different medications is often necessary. Currently available medication classes include the selective serotonin uptake inhibitors, the serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, analgesics, hypnotic agents, and anticonvulsants. Treatment modalities should be individualized for patients based on target symptoms and impairment in functioning. As is the case with several chronic disorders, the treatment is often prolonged and improvement may occur slowly. Patience and positive attitude on part of the physician and active involvement of patients and their families in treatment are likely to enhance improvement.

Entities:  

Mesh:

Year:  2003        PMID: 12773276     DOI: 10.1007/s11920-003-0046-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  54 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome.

Authors:  Gunnar Lundberg; Björn Gerdle
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

3.  A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.

Authors:  Lesley M Arnold; Evelyn V Hess; James I Hudson; Jeffrey A Welge; Sarah E Berno; Paul E Keck
Journal:  Am J Med       Date:  2002-02-15       Impact factor: 4.965

Review 4.  [Sleep in fibromyalgia: review of clinical and polysomnographic data].

Authors:  Y Dauvilliers; J Touchon
Journal:  Neurophysiol Clin       Date:  2001-02       Impact factor: 3.734

Review 5.  Current experience with 5-HT3 receptor antagonists in fibromyalgia.

Authors:  Michael Späth
Journal:  Rheum Dis Clin North Am       Date:  2002-05       Impact factor: 2.670

Review 6.  Nonpharmacologic management strategies in fibromyalgia.

Authors:  Carol S Burckhardt
Journal:  Rheum Dis Clin North Am       Date:  2002-05       Impact factor: 2.670

7.  Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

Authors:  S Carette; G A McCain; D A Bell; A G Fam
Journal:  Arthritis Rheum       Date:  1986-05

8.  Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial.

Authors:  Selwyn C M Richards; David L Scott
Journal:  BMJ       Date:  2002-07-27

9.  Electroacupuncture in fibromyalgia: results of a controlled trial.

Authors:  C Deluze; L Bosia; A Zirbs; A Chantraine; T L Vischer
Journal:  BMJ       Date:  1992-11-21

10.  A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.

Authors:  L G Quimby; G M Gratwick; C D Whitney; S R Block
Journal:  J Rheumatol Suppl       Date:  1989-11
View more
  3 in total

Review 1.  Fibromyalgia: Treating Pain in the Juvenile Patient.

Authors:  Sabrina Gmuca; David D Sherry
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

2.  Analysis of the impact of fibromyalgia on quality of life: associated factors.

Authors:  Ma Del Carmen Ubago Linares; Isabel Ruiz-Pérez; Ma José Bermejo Pérez; Antonio Olry de Labry-Lima; Elisa Hernández-Torres; Juncal Plazaola-Castaño
Journal:  Clin Rheumatol       Date:  2007-10-02       Impact factor: 2.980

Review 3.  Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis.

Authors:  Maya Levy Coles; Yosef Uziel
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-18       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.